Ibrutinib holds promise for patients with 17p deletion CLL

Research output: Contribution to journalComment/debate

Original languageEnglish
Pages (from-to)1342-1343
Number of pages2
JournalThe Lancet Oncology
Volume17
Issue number10
DOIs
Publication statusPublished - Oct 1 2016

ASJC Scopus subject areas

  • Oncology

Cite this